These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer. Lin EH; Salon C; Brambilla E; Lavillette D; Szecsi J; Cosset FL; Coll JL Cancer Gene Ther; 2010 Apr; 17(4):256-65. PubMed ID: 19893593 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia. Tan L; Jia H; Liu R; Wu J; Han H; Zuo Y; Yang S; Huang W Cancer Lett; 2009 Jan; 273(1):114-21. PubMed ID: 18783878 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas. Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967 [TBL] [Abstract][Full Text] [Related]
5. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction. Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411 [TBL] [Abstract][Full Text] [Related]
6. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Bateman AR; Harrington KJ; Kottke T; Ahmed A; Melcher AA; Gough MJ; Linardakis E; Riddle D; Dietz A; Lohse CM; Strome S; Peterson T; Simari R; Vile RG Cancer Res; 2002 Nov; 62(22):6566-78. PubMed ID: 12438252 [TBL] [Abstract][Full Text] [Related]
7. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Diaz RM; Bateman A; Emiliusen L; Fielding A; Trono D; Russell SJ; Vile RG Gene Ther; 2000 Oct; 7(19):1656-63. PubMed ID: 11083474 [TBL] [Abstract][Full Text] [Related]
8. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy. Ahmed A; Jevremovic D; Suzuki K; Kottke T; Thompson J; Emery S; Harrington K; Bateman A; Vile R Gene Ther; 2003 Sep; 10(19):1663-71. PubMed ID: 12923565 [TBL] [Abstract][Full Text] [Related]
10. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Bateman A; Bullough F; Murphy S; Emiliusen L; Lavillette D; Cosset FL; Cattaneo R; Russell SJ; Vile RG Cancer Res; 2000 Mar; 60(6):1492-7. PubMed ID: 10749110 [TBL] [Abstract][Full Text] [Related]
11. Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells. Gómez-Treviño A; Castel S; López-Iglesias C; Cortadellas N; Comas-Riu J; Mercadé E J Gene Med; 2003 Jun; 5(6):483-92. PubMed ID: 12797113 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. Zhang J; Frolov I; Russell SJ J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589 [TBL] [Abstract][Full Text] [Related]
13. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159 [TBL] [Abstract][Full Text] [Related]
14. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells. Partheniou F; Kelsey SM; Srinivasula SM; Newland AC; Alnemri ES; Jia L Biochem Biophys Res Commun; 2001 Sep; 287(1):181-9. PubMed ID: 11549272 [TBL] [Abstract][Full Text] [Related]
15. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution. Guedan S; Grases D; Rojas JJ; Gros A; Vilardell F; Vile R; Mercade E; Cascallo M; Alemany R Gene Ther; 2012 Nov; 19(11):1048-57. PubMed ID: 22113313 [TBL] [Abstract][Full Text] [Related]
16. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Wu SJ; Ng LT; Lin CC Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Steinbach JP; Wolburg H; Klumpp A; Probst H; Weller M Cell Death Differ; 2003 Jul; 10(7):823-32. PubMed ID: 12815465 [TBL] [Abstract][Full Text] [Related]
19. Cholinergic-receptor-independent dysfunction of mitochondrial respiratory chain enzymes, reduced mitochondrial transmembrane potential and ATP depletion underlie necrotic cell death induced by the organophosphate poison mevinphos. Chan JY; Chan SH; Dai KY; Cheng HL; Chou JL; Chang AY Neuropharmacology; 2006 Dec; 51(7-8):1109-19. PubMed ID: 16984802 [TBL] [Abstract][Full Text] [Related]
20. Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication. Guedan S; Gros A; Cascallo M; Vile R; Mercade E; Alemany R Gene Ther; 2008 Sep; 15(17):1240-5. PubMed ID: 18509378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]